瘤微环境:从宫癌发生到治疗进步
Srishti Sharma1, Meenakshi Verma2, Indra Rautela3
1Department of Biotechnology, GLA University, Mathura, India.
Current pharmaceutical biotechnology
|September 5, 2024
概括
宫癌研究强调瘤微环境 (TME) 对于瘤生长和治疗耐药性至关重要. 针对TME提供了改善治疗和提高宫癌妇女生活质量的潜力.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 子宫癌是全球领先的健康问题,每年影响超过30万名女性.
- 瘤微环境 (TME) 显著影响瘤的生存,进展和治疗反应.
- 关键的TME特征包括免疫抑制,缺氧,酸度和营养缺乏.
研究的目的:
- 提供关于瘤微环境在宫癌中的作用的全面概述.
- 探索单个TME组件在癌症发展和进展中的功能.
- 在TME中确定潜在的治疗点,以改善宫癌治疗.
主要方法:
- 关于宫癌瘤微环境的最新研究的文献综述.
- 对TME组件对瘤生物学影响的分析.
- 确定针对TME的新兴治疗策略.
主要成果:
- TME包括各种细胞 (瘤,免疫,介质细胞,纤维细胞) 和细胞外基质.
- TME组件重编程瘤的发展,扩散,入侵,转移和治疗反应.
- 特定的TME特征创造了一个复杂的景观,促进瘤存活.
结论:
- 向瘤微环境是治疗宫癌的有希望的策略.
- 了解TME可以导致更有效的治疗,副作用更少.
- 专注于TME的未来研究和治疗干预有可能显著改善宫癌患者的治疗结果.
更多相关视频
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347


